This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Peter Pallai
Introduction
Peter Pallai is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of virology through his innovative research and patents. His work focuses on the expression of viral proteases, which are crucial in understanding and combating viral infections.
Latest Patents
Peter Pallai holds a patent for the "Expression of the virally coded protease P2A of HRV2." This invention relates to a DNA molecule or a functional derivative thereof coding for a fusion protein. The fusion protein comprises an enzymatically active component and a non-enzymatically active polypeptide component, which may be cleaved therefrom. The patent also includes an expression system that contains the DNA molecule, its use as a test system for inhibitors of viral proteases, and an assay for identifying viral inhibitors. This patent highlights his innovative approach to addressing viral challenges.
Career Highlights
Peter Pallai is associated with Boehringer Ingelheim International GmbH, where he continues to contribute to advancements in pharmaceutical research. His work has been instrumental in developing new methodologies for studying viral proteases, which are essential for the development of antiviral therapies.
Collaborations
Peter has collaborated with esteemed colleagues such as Heinrich Kowalski and Friederike Fessl. These collaborations have further enriched his research and have led to significant advancements in the field.
Conclusion
Peter Pallai's contributions to virology through his innovative patents and collaborations underscore his importance in the scientific community. His work continues to pave the way for new treatments and understanding of viral infections.